- Letermovir Prophylaxis for Cytomegalovirus Reactivation in β Thalassemia Major Children after Hematopoietic Cell TransplantationShi, Lingling; Liu, Rongrong; Zhang, Zhongming; Huang, Cuifeng; Liu, Lianjin; Yao, Yibin; Wei, Zhenbin; Wei, Shuyi; Gan, Zhaoping; Sun, Na; Liu, Beicai; Huang, Rui; Zhou, Xuemei; Chen, Yinghua; Liu, Qifa; Lai, Yongrong65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Haploidentical Stem Cell Transplantation Had a Lower Incidence of Bronchiolitis Obliterans Syndrome Compared with HLA-Matched Sibling Transplantation for Patients with Hematologic Malignancies: Benefit from ATG?Weng, Guangyang; Fan, Zhiping; Huang, Fen; Xu, Na; Jin, Hua; Yu, Sijian; Xuan, Li; Liu, Qifa64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- Improving Outcomes for Children Requiring Extracorporeal Membrane Oxygenation Therapy Following Hematopoietic Stem Cell TransplantationTaylor L., Olson; Erika R., O’Neil; Kristen J., Kurtz; Graeme, MacLaren; Marc M., AndersCritical Care Medicine, 2021, 49(4): e381-e393.
会议论文
Impact of COVID-19 in Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplant Recipients
1阅读
